Načítá se...
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms
The therapeutic potential of arsenic derivatives has long been recognized and was recently rediscovered in modern literature. Early studies demonstrated impressive activity of this compound in patients with relapsed acute promyelocytic leukemia (APL). Over the last 2 decades intravenous arsenic trio...
Uloženo v:
| Vydáno v: | Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042140/ https://ncbi.nlm.nih.gov/pubmed/26716387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29852 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|